Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesTrastuzumab-Induced Cardiomyopathy: Not as Benign as it Looks? A Retrospective Study
Journal of Cardiac Failure, 09/29/09
Guglin M et al. – Cardiomyopathy is a common side effect of trastuzumab that leads to discontinuation of treatment in a significant proportion of patients. Further studies are indicated to establish the ways to predict, prevent, and treat cardiomyopathy to provide patients with maximal therapeutic benefit of trastuzumab.
Related Articles
The role of MRI in peripartum cardiomyopathy
International Journal of Cardiology, 10/15/09
Relevance Score: 89%
Defects in long chain fatty acid oxidation presenting as severe cardiomyopathy and cardiogenic shock in infancy
Cardiology in the Young, 10/21/09
Relevance Score: 88%
Celiac Disease Associated with Dilated Cardiomyopathy
Southern Medical Journal, 10/07/09
Relevance Score: 88%
Can peripartum cardiomyopathy be familial
International Journal of Cardiology, 10/14/09
Relevance Score: 87%
Cardiac insulin-like growth factor-1 and cyclins gene expression in canine models of ischemic or overpacing cardiomyopathy
BMC Cardiovascular Disorders, 10/14/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Atorvastatin Inhibits gp91phox Circulating Levels in Patients With Hypercholesterolemia
Arteriosclerosis, Thrombosis, and Vascular Biology, 12/17/09
Clopidogrel Hypersensitivity: A Novel Multi-Day Outpatient Oral Desensitization Regimen
Annals of Pharmacotherapy, 12/16/09
Thiazolidinediones and the liver in humans
Current Opinion in Lipidology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor